Perreault L,Skyler JS,Rosenstock J .2021 .Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nat Rev Endocrinol, 17(6) : 364-77.
Halim M,Halim A .2019 .The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr, 01(2) : 1165-72.
Magliano DJ,Boyko EJ .2021 .IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. 10th ed. Int Diabetes Fed, : .
Goyal R,Singhal M,Jialal I,Castano M. .2023 .Type 2 Diabetes (Nursing). , : .
Caturano A,D'Angelo M,Mormone A,Russo V,Mollica MP,Salvatore T .2023 .Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol, 45(8) : 6651-66.
Przezak A,Bielka W,Pawlik A .2022 .Hypertension and type 2 diabetes-the novel treatment possibilities. Int J Mol Sci, 23(12) : 6500.
Ward K,Mulder E,Frings-Meuthen P,O'Gorman DJ,Cooper D .2020 .Fetuin-A as a potential biomarker of metabolic variability following 60 days of bed rest. Front Physiol, 11 : 573581.
Bourebaba L,Marycz K. .2033 .Pathophysiological implication of fetuinA glycoprotein in the development of metabolic disorders: a concise review. J Clin Med, 8(12) : .
Sardana O,Goyal R,Bedi O .2021 .Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. , 29(4) : 1061-74.
Stefan N,Fritsche A,Weikert C,Boeing H,Joost HG,Häring HU .2008 .Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes, 57(10) : 0538-7.
Fadel MM,Ghaffar FR,Zwain SK,Ibrahim HM .2021 .Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus. Biochem Biophys Rep, 27 : 101045.
Ziegon L,Schlegel M .2021 .Netrin-1: A modulator of macrophage driven acute and chronic inflammation. Int J Mol Sci, 23(1) : 275.
Nedeva I,Gateva A,Assyov Y,Karamfilova V,Velikova T .2020 .Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes. Arch Physiol Biochem, 128(6) : 1533-8.
DeFronzo RA,Tripathy D. .2009 .Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care, 32(Suppl 2) : .
Suvitaival T,Mantere O,Kieseppä T,Mattila I,Pöhö P,Hyötyläinen T .2016 .Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry, 6(11) : e951.
Puchalska P,Crawford PA. .2016 .Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab, 12(2) : 262-84.
Mahendran Y,Jonsson A,Have CT,Allin KH,Witte DR,Jørgensen ME .2017 .Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia, 60(5) : 873-8.
Lin JD,Chen YL,Wu CZ,Hsieh CH,Pei D,Liang YJ .2016 .Identification of normal blood pressure in different age groups. Medicine, 95(14) : .
Majid H,Masood Q,Khan AH .2017 .Homeostatic model assessment for insulin resistance (HOMA-IR): a better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome. J Coll Physicians Surg Pak, 27(3) : 123-6.
Lanthier N,Lebrun V,Molendi-Coste O,van Rooijen N,Leclercq IA .2022 .Liver fetuin-A at initiation of insulin resistance. Metabolites, 12(11) : 1023.
Afrisham R,Hashemnia SM,Majidi Z,Mozaffari S,Vahidi M. .2020 .Association of fetuin-A with the pathogenesis of metabolic diseases. Int J Biomed Public Health, 3(3) : 95-102.
Brix JM,Stingl H,Höllerl F,Schernthaner GH,Kopp HP,Schernthaner G .2010 .Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab, 95(11) : 0148-81.
Guo VY,Cao B,Cai C,Cheng KK,Cheung BMY .2018 .Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol, 55 : 87-98.
Sujana C,Huth C,Zierer A,Meesters S,Sudduth-Klinger J,Koenig W .2018 .Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis. Eur J Endocrinol, 178(4) : 389-98.
Goustin AS,Derar N,Abou-Samra AB .2012 .Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor. Cell Signal, 12(4) : 981-8.
Xia X,Hu Z,Wang S,Yin K. .2022 .Netrin-1: An emerging player in inflammatory diseases. Cytokine Growth Factor Rev, 01 : 46-56.
Shalaby A,El Mancy IM .2021 .Study of serum Netrin-1 level in prediabetics and type 2 diabetic Egyptian patients. Al-Azhar Int Med, 2(6) : 17-22.
Yimer EM,Zewdie KA,Hishe HZ,Diabetes‐Associated Complications HZ .2018 .Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus. J Diabetes Res, : 8250521.
Natura G,Bär KJ,Eitner A,Boettger MK,Richter F,Hensellek S .2013 .Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. Proc Natl Acad Sci, 110(33) : 13648-53.
Ramkhelawon B,Hennessy EJ,Ménager M,Ray TD,Sheedy FJ,Hutchison S . .Netrin-1 promotes adipose tissue. , : .
Ferrannini E,Natali A,Camastra S,Nannipieri M,Mari A,Adam KP .2013 .Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes, 62(5) : 0707-7.
Menni C,Fauman E,Erte I,Perry JR,Kastenmüller G,Shin SY .2013 .Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes, 62(12) : 0570-6.
Padberg I,Peter E,González-Maldonado S,Witt H,Mueller M,Weis T .2014 .A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS One, 9(1) : .
Dudzik D,Zorawski M,Skotnicki M,Zarzycki W,García A,Angulo S .2017 .GC-MS based Gestational Diabetes Mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers. J Pharm Biomed Anal, 02 : 90-8.
Varvel SA,Pottala JV,Thiselton DL,Caffrey R,Dall T,Sasinowski M .2014 .Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT. -000038, 2(1) : .
Karpe F,Dickmann JR,Frayn KN .2011 .Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes, 60(10) : 0425-9.
Cobb J,Gall W,Adam KP,Nakhle P,Button E,Hathorn J .2013 .A novel fasting blood test for insulin resistance and prediabetes. J Diabetes Sci Technol, 7(1) : 100-10.
Sarı H,Esen B,Yıldırım S,Pilten S,Aydın H.,Serum H. .2016 .- hydroxybutyrate: a candidate marker of insulin resistance is associated with deterioration in anthropometric measurements in individuals with low diabetes risk. J Appl Lab Med, 1(5) : 562-7.
Tseng Z,White Y,MF Y .2010 .Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab, 06(10) : 589-98.
Ix JH,Shlipak MG,Brandenburg VM,Ali S,Ketteler M,Whooley MA .2006 .Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation, 113(14) : 1760-7.
Stefan N,Hennige AM,Staiger H,Machann J,Schick F,Kröber SM .2006 .-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 29(4) : 1938-7.
Reinehr T,Roth CL .2008 .Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab, 93(11) : 1505-85.
Al-Shakour AA,Khalid HK,Mahmood I,Al-Sudani MY,Majeed M. .2024 .Serum netrin-1 level in patients with type 2 diabetes mellitus and its relationship with diabetic complications. Anaesth Pain Intensive Care, 28(2) : 347-52.
Jebar RS,Saleh BO,Almaliky AA .2023 .Alpha hydroxyl butyrate as a marker for prediction of familial type 2 diabetes mellitus in Iraqi apparently healthy. Acta Biomed, 94(2) : .
Gall WE,Beebe K,Lawton KA,Adam KP,Mitchell MW,Nakhle PJ .2010 .α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One, 5(5) : .
Lotta LA,Scott RA,Sharp SJ,Burgess S,Luan JA,Tillin T .2016 .Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a Mendelian randomisation analysis. PLoS Med, 13(11) : .